ABSTRACT
The heme oxygenase-carbon monoxide pathway has been shown to play an important role in many physiological processes and is capable of altering nociception modulation in the nervous system by stimulating soluble guanylate cyclase (sGC). In the central nervous system, the locus coeruleus (LC) is known to be a region that expresses the heme oxygenase enzyme (HO), which catalyzes the metabolism of heme to carbon monoxide (CO). Additionally, several lines of evidence have suggested that the LC can be involved in the modulation of emotional states such as fear and anxiety. The purpose of this investigation was to evaluate the activation of the heme oxygenase-carbon monoxide pathway in the LC in the modulation of anxiety by using the elevated plus maze test (EPM) and light-dark box test (LDB) in rats. Experiments were performed on adult male Wistar rats weighing 250-300 g (n=182). The results showed that the intra-LC microinjection of heme-lysinate (600 nmol), a substrate for the enzyme HO, increased the number of entries into the open arms and the percentage of time spent in open arms in the elevated plus maze test, indicating a decrease in anxiety. Additionally, in the LDB test, intra-LC administration of heme-lysinate promoted an increase on time spent in the light compartment of the box. The intracerebroventricular microinjection of guanylate cyclase, an sGC inhibitor followed by the intra-LC microinjection of the heme-lysinate blocked the anxiolytic-like reaction on the EPM test and LDB test. It can therefore be concluded that CO in the LC produced by the HO pathway and acting via cGMP plays an anxiolytic-like role in the LC of rats.
Subject(s)
Animals , Male , Rats , Anti-Anxiety Agents/pharmacology , Anxiety/metabolism , Behavior, Animal/drug effects , Carbon Monoxide/metabolism , Heme Oxygenase (Decyclizing)/metabolism , Locus Coeruleus/metabolism , Signal Transduction/physiology , Carbon Monoxide/physiology , Guanylate Cyclase/metabolism , Locus Coeruleus/drug effects , Locus Coeruleus/physiology , Maze Learning , Rats, WistarABSTRACT
Endogenous carbon monoxide (CO), which is produced by the enzyme heme oxygenase (HO), participates as a neuromodulator in physiological processes such as thermoregulation and nociception by stimulating the formation of 3′,5′-cyclic guanosine monophosphate (cGMP). In particular, the acute physical restraint-induced fever of rats can be blocked by inhibiting the enzyme HO. A previous study reported that the HO-CO-cGMP pathway plays a key phasic antinociceptive role in modulating noninflammatory acute pain. Thus, this study evaluated the involvement of the HO-CO-cGMP pathway in antinociception induced by acute stress in male Wistar rats (250-300 g; n=8/group) using the analgesia index (AI) in the tail flick test. The results showed that antinociception induced by acute stress was not dependent on the HO-CO-cGMP pathway, as neither treatment with the HO inhibitor ZnDBPG nor heme-lysinate altered the AI. However, antinociception was dependent on cGMP activity because pretreatment with the guanylate cyclase inhibitor 1H-[1,2,4] oxadiazolo [4,3-a] quinoxaline-1-one (ODQ) blocked the increase in the AI induced by acute stress.
Subject(s)
Animals , Male , Acute Pain/prevention & control , Carbon Monoxide/metabolism , Cyclic GMP/metabolism , Heme Oxygenase (Decyclizing)/metabolism , Nociceptive Pain/prevention & control , Stress Disorders, Traumatic, Acute/metabolism , Cyclic GMP/antagonists & inhibitors , Deuteroporphyrins/metabolism , Heme Oxygenase (Decyclizing)/antagonists & inhibitors , Heme/analogs & derivatives , Heme/metabolism , Lysine/analogs & derivatives , Lysine/metabolism , Nociceptive Pain/metabolism , Oxadiazoles/pharmacology , Pain Measurement/methods , Rats, Wistar , Signal Transduction/physiologyABSTRACT
We have shown that the peripheral and spinal cord heme oxygenase (HO)-carbon monoxide (CO)-soluble guanylate cyclase-cGMP pathways play an important role in antinociception in the rat experimental formalin model. Our objective was to determine if there is synergism between peripheral (paw) and spinal HO-CO pathways in nociception. Rats were handled and adapted to the experimental environment for a few days before the formalin test, in which 50 µL of a 1 percent formalin was injected subcutaneously into the dorsal surface of the right hind paw. The animals were then observed for 1 h and the frequency of flinching behavior was taken to represent the nociceptive response. Thirty minutes before the test, rats were pretreated with intrathecal injections of the HO inhibitor, zinc deuteroporphyrin 2,4-bis glycol (ZnDPBG) or heme-lysinate, which is a substrate of the HO pathway. The paw treatments took place 20 min before the test. Low doses of ZnDPBG did not increase nociception, while a low heme-lysinate dose did not change flinching behavior after paw or spinal injections. Combined subactive spinal (50 nmol) and peripheral (40 nmol) low doses of ZnDPBG induced hypernociception (increase of 80 percent in the first and 25 percent in the second phase flinching), whereas combined spinal-peripheral heme-lysinate (50 and 30 nmol) led to second phase antinociception (40 percent reduction in flinching). These findings suggest a synergy between the peripheral and spinal HO-CO pathways. Local activation of the HO system probably regulates the nociception initiation in peripheral tissue and participates in buffering the emerging nociceptive signals at the peripheral and spinal sites of action. In short, an antinociceptive synergy exists between peripheral and spinal HO pathways, which may reduce the doses required and side effects.
Subject(s)
Animals , Male , Rats , Carbon Monoxide/metabolism , Guanylate Cyclase/administration & dosage , Heme Oxygenase (Decyclizing)/metabolism , Nociceptors/drug effects , Pain Measurement/drug effects , Receptors, Cytoplasmic and Nuclear/administration & dosage , Spinal Cord/drug effects , Dose-Response Relationship, Drug , Drug Synergism , Guanylate Cyclase/pharmacology , Heme Oxygenase (Decyclizing)/drug effects , Injections, Spinal , Nociceptors/physiology , Rats, Wistar , Signal Transduction , Spinal Cord/physiologyABSTRACT
The interaction between pulmonary ventilation (V E) and body temperature (Tb) is essential for O2 delivery to match metabolic rate under varying states of metabolic demand. Hypoxia causes hyperventilation and anapyrexia (a regulated drop in Tb), but the neurotransmitters responsible for this interaction are not well known. Since L-glutamate is released centrally in response to peripheral chemoreceptor stimulation and glutamatergic receptors are spread in the central nervous system we tested the hypothesis that central L-glutamate mediates the ventilatory and thermal responses to hypoxia. We measured V E and Tb in 40 adult male Wistar rats (270 to 300 g) before and after intracerebroventricular injection of kynurenic acid (KYN, an ionotropic glutamatergic receptor antagonist), alpha-methyl-4-carboxyphenylglycine (MCPG, a metabotropic glutamatergic receptor antagonist) or vehicle (saline), followed by a 1-h period of hypoxia (7 percent inspired O2) or normoxia (humidified room air). Under normoxia, KYN (N = 5) or MCPG (N = 8) treatment did not affect V E or Tb compared to saline (N = 6). KYN and MCPG injection caused a decrease in hypoxia-induced hyperventilation (595 ± 49 for KYN, N = 7 and 525 ± 84 ml kg-1 min-1 for MCPG, N = 6; P < 0.05) but did not affect anapyrexia (35.3 ± 0.2 for KYN and 34.7 ± 0.4ºC for MCPG) compared to saline (912 ± 110 ml kg-1 min-1 and 34.8 ± 0.2ºC, N = 8). We conclude that glutamatergic receptors are involved in hypoxic hyperventilation but do not affect anapyrexia, indicating that L-glutamate is not a common mediator of this interaction.
Subject(s)
Animals , Male , Rats , Body Temperature , Glutamic Acid , Hyperventilation , Hypoxia , Kynurenic Acid , Body Temperature Regulation , Injections, Intraventricular , Rats, WistarABSTRACT
Several species of terrestrially hibernating frogs, turtles and inserts have developed mechanisms, such as increased plasma glucose, anti-freeze proteins and antioxidant enzymes that resist to freezing, for survival at subzero temperatures. In the present study, we assessed the importance of glucose to cryoresistance of two anuran amphibians: the frog Rana catesbeiana and the toad Bufo paracnemis. Both animals were exposed to -2 degrees Celsius for measurements of plasma glucose levels, liver and muscle glycogen content, haematocrit and red blood cell volume. Frogs survived cold exposure but toads did not. Blood glucose concentration increased from 40.35 + 7.25 to 131.87 + 20.72 mg/dl (P < 0.01) when the frogs were transferred from 20 to -2 degrees Celsius. Glucose accumulation in response to cold exposition in the frogs was accompanied by a decrease (P < 0.05) in liver glycogen content from 3.94 + 0.42 to 1.33 + 0.36 mg/100 mg tissue, indicating that liver carbohydrate reserves were probably the primary carbon source of glucose synthesis whereas muscle carbohydrate seems unimportant. In the toads, the cold-induced hyperglycaemia was less (P < 0.05) pronounced (from 27.25 + 1.14 to 73.72 + 13.50 mg/dl) and no significant change could be measured in liver or muscle glycogen. Cold exposition had no effect on the haematocrit of the frogs but significantly reduced (P < 0.01) the haematocrit of toads from 20.0 + 2.1 per cent to 5.8 + 1.7 per cent due to a decreased red blood cell volume (from 1532 + 63 70 728 + 87 mm3). When toads were injected with glucose, blood glucose increased to levels similar to those of frogs and haematocrit did not change, but this failed to make them cryoresistent. In conclusion, the lack of cold-induced glucose catabolism may not be the only mechanism responsible for the freeze intolerance of Bufo paracnemis, a freeze-intolerant species.
Subject(s)
Animals , Male , Female , Acclimatization/drug effects , Bufonidae/physiology , Freezing , Glucose/pharmacology , Rana catesbeiana/physiology , Blood Glucose/analysis , Cell Size , Erythrocytes/cytology , Glycogen/analysis , Hematocrit , Liver/chemistry , Muscles/chemistryABSTRACT
Hypoxia elicits hyperventilation and hypothermia, but the mechanisms involved are not well understood. The nitric oxide (NO) pathway is involved in hypoxia-induced hypothermia and hyperventilation, and works as a neuromodulator in the central nervous system, including the locus coeruleus (LC), which is a noradrenergic nucleus in the pons. The LC plays a role in a number of stress-induced responses, but its participation in the control of breathing and thermoregulation is unclear. Thus, in the present study, we tested the hypothesis that LC plays a role in the hypoxia-induced hypothermia and hyperventilation, and that NO is involved in these responses. Electrolytic lesions were performed bilaterally within the LC in awake unrestrained adult male Wistar rats weighing 250-350 g. Body temperature and pulmonary ventilation (VE) were measured. The rats were divided into 3 groups: control (N = 16), sham operated (N = 7) and LC lesioned (N = 19), and each group received a saline or an NG-nitro-L-arginine methyl ester (L-NAME, 250 µg/µl) intracerebroventricular (icv) injection. No significant difference was observed between control and sham-operated rats. Hypoxia (7 per cent inspired O2) caused hyperventilation and hypothermia in both control (from 541.62 + or - 35.02 to 1816.18 + or - 170.7 and 36.3 + or - 0.12 to 34.4 + or - 0.09, respectively) and LC-lesioned rats (LCLR) (from 694.65 + or - 63.17 to 2670.29 + or - 471.33 and 36 + or - 0.12 to 35.3 + or - 0.12, respectively), but the increase in VE was higher (P<0.05) and hypothermia was reduced (P<0.05) in LCLR. L-NAME caused no significant change in VE or in body temperature under normoxia, but abolished both the hypoxia-induced hyperventilation and hypothermia. Hypoxia-induced hyperventilation was reduced in LCLR treated with L-NAME. L-NAME also abolished the hypoxia-induced hypothermia in LCLR. The present data indicate that hypoxia-induced hyperventilation and hypothermia may be related to the LC, and that NO is involved in these responses.
Subject(s)
Animals , Male , Rats , Hyperventilation/etiology , Hyperventilation/physiopathology , Hypothermia/etiology , Hypothermia/physiopathology , Hypoxia, Brain , Locus Coeruleus/physiology , Nitric Oxide/physiology , Body Temperature , Enzyme Inhibitors/pharmacology , NG-Nitroarginine Methyl Ester/pharmacology , Rats, WistarABSTRACT
The nucleus isthmi (NI) is a mesencephalic structure of the amphibian brain. It has been reported that NI plays an important role in integration of CO2 chemoreceptor information and glutamate is probably involved in this function. However, very little is known about the mechanisms involved. Recently, it has been shown that nitric oxide synthase (NOS) is expressed in the brain of the frog. Thus the gas nitric oxide (NO) may be involved in different functions in the brain of amphibians and may act as a neurotransmitter or neuromodulator. We tested the hypothesis that NO plays a role in CO2-drive to breathing, specifically in the NI comparing pulmonary ventilation, breathing frequency and tidal volume, after microinjecting 100 nmol/0.5 µl of L-NAME (a nonselective NO synthase inhibitor) into the NI of toads (Bufo paracnemis) exposed to normocapnia and hypercapnia. Control animals received microinjections of vehicle of the same volume. Under normocapnia no significant changes were observed between control and L-NAME-treated toads. Hypercapnia caused a significant (P<0.01) increase in ventilation only after intracerebral microinjection of L-NAME. Exposure to hypercapnia caused a significant increase in breathing frequency both in control and L-NAME-treated toads (P<0.01 for the control group and P<0.001 for the L-NAME group). The tidal volume of the L-NAME group tended to be higher than in the control group under hypercapnia, but the increase was not statistically significant. The data indicate that NO in the NI has an inhibitory effect only when the respiratory drive is high (hypercapnia), probably acting on tidal volume. The observations reported in the present investigation, together with other studies on the presence of NOS in amphibians, indicate a considerable degree of phylogenetic conservation of the NO pathway amongst vertebrates.
Subject(s)
Animals , Carbon Dioxide , Mesencephalon/physiology , Nitric Oxide/physiology , Respiration , Anura , Blood Pressure , Enzyme Inhibitors/pharmacology , Heart Rate , Hypercapnia , NG-Nitroarginine Methyl Ester/pharmacologyABSTRACT
The objective of the present study was to determine the effects hypoxia and temperature on the cardiovascular and respiratory systems tems and plasma glucose levels of the winter bullfrog Rana calesbeiana. Body temperature was maintained at 10, 15, 25 and 35 degrees Celsius for measments of breathing frequency, heart rate, arterial blood pressure metabolic rate, plasma glucose levels, blood gases and acid-base status. Reducing body temperature from 35 to 10 degrees Celsius decreased (P<0.001) heart rate (bpm) from 64.0 ñ 3,1 (N =5) to 12.5 + 2.5 (N = 6) and blood pressure (mmHg) (P<0.05) from 41.9 ñ 2.1 (N = 5) to 33.1 ñ 2.1 (N = 6), whereas no significant changes were observed under hypoxia. Hypoxia-induced changes in breathing frequency and acid-base status were proportional to body ternperature, being pronounced at 25 degrees Celsius less so at l5 degrees Celsius, and absent at 10 degrees Celsius. Hypoxia at 35 degrees Celsius was lethal. Under normoxia, plasma glucose concentration (mg/dl) decreased (P<0.01 from 53.0 ñ 3.4 (N = 6) to 35.9 ñ 1.7 (N = 6) at body temperatures 35 and 10 degrees Celsius, respectively. Hypoxia had no significant effect on plasma glucose concentration at 10 and 15 degrees Celsius, but a 25 degrees Celsius there was a significant increase under conditions of 3 per cent inspired O2. The arterial PO2 and pH values were similar to those reported in previous studies on non-estivating Rana calesbeiana, but PaCO2 (37.5 ñ 1.9 mmHg, N = 5) was 3-fold higher, indicating increased plasma bicarbonate levels. The estivating bullfrog may be exposed not only to low temperatures but also to hypoxia. These animals show temperature-dependent responses that may be beneficial since during low body temperatures but also to hypoxia. These animals show temperature-dependent responses that may be beneficial since during low body temperatures the sensitivity of most physiological systems to hypoxia is reduced.
Subject(s)
Animals , Male , Female , Cardiovascular System/physiology , Hypoxia/complications , Metabolism/physiology , Rana catesbeiana/physiology , Respiratory System/physiology , ThermosensingABSTRACT
In vertebrate evolution, the transition from aquatic to terrestrial mode of life was associated with considerable changes in the respiratory system and CO2/pH-sensitive receptors became fundamental. The present review focuses on the combined effects of hypercapnia and body temperature in anuran amphibians, that represent a key group for the transition. Recent studies have indicated that temperature affects the hypercapnic drive to breathe. Conversely, hypercapnia modulates the range of preferred body temperature of amphibians and central (CO2/pH) receptors are likely to be involved.